Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR4883] to TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) - BSA and Azide free
  • Suitable for: WB, IHC-P
  • Reacts with: Mouse, Rat, Human

Overview

  • Product name

    Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free

  • Description

    Rabbit monoclonal [EPR4883] to TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) - BSA and Azide free

  • Host species

    Rabbit

  • Specificity

    This antibody recognizes Human TAOK1 when phosphorylated at Serine 181, TAOK2 when phosphorylated at Serine 181 and TAOK3 when phosphorylated at Serine 177.

  • Tested applications

    Suitable for: WB, IHC-Pmore details
    Unsuitable for: ICC or IP

  • Species reactivity

    Reacts with: Mouse, Rat, Human

  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • General notes

    Ab248030 is the carrier-free version of ab124841. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    ab248030 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Western blot - Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)
    Western blot - Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)
    All lanes : Anti-KDS (phospho S177) + TAOK2 (phospho S181) + TAOK1 (phospho S181) antibody [EPR4883] (ab124841) at 1/1000 dilution

    Lane 1 : Untreated 293T cell lysates
    Lane 2 : Lambda Phosphatase treated 293T cell lysates

    Lysates/proteins at 10 µg per lane.

    Predicted band size: 138 kDa



    This data was developed using ab124841, the same antibody clone in a different buffer formulation.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)
    This data was developed using ab124841, the same antibody clone in a different buffer formulation.ab124841, at 1/250 to 1/500, staining TAOK3 (phospho S177) + TAOK2 (phospho S181) + TAOK1 (phospho S181) in Human colonic adenocarcinoma by immunohistochemistry [Paraffin Embedded Tissues (IHC-P)]. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
  • Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)
    Anti-TAOK2 + TAOK1 + TAOK3 (phospho S177 + S181 + S181) antibody [EPR4883] - BSA and Azide free (ab248030)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.